Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol

被引：0
|
作者：
Qiang-ling Sun
Hui-fang Sha
Xiao-hua Yang
Guo-liang Bao
Jing Lu
Yin-yin Xie
机构：
[1] Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University,Basic Research Laboratory
[2] Ruijin Hospital of Shanghai Jiaotong University,Institute of Hematology
来源：
Journal of Cancer Research and Clinical Oncology | 2011年 / 137卷
关键词：
Chemoresistance; Non-Small Cell Lung Cancer (NSCLC); Paclitaxel; Two-dimensional difference gel electrophoresis (2D-DIGE);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：521 / 532
页数：11
相关论文
共 50 条
  • [1] Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
    Sun, Qiang-ling
    Sha, Hui-fang
    Yang, Xiao-hua
    Bao, Guo-liang
    Lu, Jing
    Xie, Yin-yin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (03) : 521 - 532
  • [2] Altered Mitochondrial Dynamics, Biogenesis, and Functions in the Paclitaxel-Resistant Lung Adenocarcinoma Cell Line A549/Taxol
    Zhou, Xiang
    Li, Rui
    Chen, Ruohua
    Liu, Jianjun
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [3] Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone
    Padar, S
    van Breemen, Z
    Thomas, DW
    Uchizono, JA
    Livesey, JC
    Rahimian, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (02) : 305 - 316
  • [4] LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
    Hao Huang
    Tian-Tian Tong
    Lee-Fong Yau
    Cheng-Yu Chen
    Jia-Ning Mi
    Jing-Rong Wang
    Zhi-Hong Jiang
    BMC Cancer, 18
  • [5] Characterization of salvicine-resistant lung adenocarcinoma A549/SAL cell line
    Miao, ZH
    Tong, LJ
    Zhang, JS
    Han, JX
    Ding, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (05) : 627 - 632
  • [6] LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
    Huang, Hao
    Tong, Tian-Tian
    Yau, Lee-Fong
    Chen, Cheng-Yu
    Mi, Jia-Ning
    Wang, Jing-Rong
    Jiang, Zhi-Hong
    BMC CANCER, 2018, 18
  • [7] Antitumor Activity of Acriflavine in Lung Adenocarcinoma Cell Line A549
    Lee, Chia-Jen
    Yue, Chia-Herng
    Lin, Yu-Jie
    Lin, Yu-Yu
    Kao, Shao-Hsuan
    Liu, Jer-Yuh
    Chen, Yieng-How
    ANTICANCER RESEARCH, 2014, 34 (11) : 6467 - 6472
  • [8] Promoter Methylation Profiles between Human Lung Adenocarcinoma Multidrug Resistant A549/Cisplatin (A549/DDP) Cells and Its Progenitor A549 Cells
    Guo, Ruiling
    Wu, Guoming
    Li, Haidong
    Qian, Pin
    Han, Juan
    Pan, Feng
    Li, Wenbi
    Li, Jin
    Ji, Fuyun
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (08) : 1310 - 1316
  • [9] Effects of paclitaxel on cell proliferation and apoptosis and its mechanism in human lung adenocarcinoma A549 cells
    Baoan Gao1
    2Department of Respiratory Medicine
    3Department of Respiratory Medicine
    4Department of Cardiology
    JournalofNanjingMedicalUniversity, 2006, (06) : 360 - 364
  • [10] In vitro effects of pyrrolizidine alkaloids in the lung adenocarcinoma cell line A549
    Buchmuller, J.
    Pellowski, D.
    Braeuning, A.
    Hessel-Pras, S.
    TOXICOLOGY LETTERS, 2021, 350 : S96 - S96
12345